- Mark your calendar for APACC 2020. Early fee discount is available until 20 December. Click here to read more.
- Revisit APACC 2019.
It is our pleasure to announce that the Asia Pacific AIDS & Co-infections Conference (APACC) 2020 is tentatively scheduled to take place on 18-20 June 2020.
Over the years enormous progress has been made in the fight against HIV and co-infections with HIV. Both academia and industry have contributed greatly to equipping the medical community with the best medications and expertise possible to optimally treat their HIV and co-infected patients. However, the international platforms for scientific interchange are not always accessible to medical professionals worldwide due to budget and travel restrictions. Also, these major events do not usually address local and regional issues. In particular, the Asian medical community in this field of research is facing challenges in this regard as there is currently no platform that serves the needs of HIV healthcare professionals in this region.
APACC provides a much-needed scientific platform that focuses on the developments, issues and needs in the Asia Pacific region. Researchers have the opportunity to present and discuss the latest developments and are offered opportunities for interaction, networking and building collaborations. Top experts integrate science and clinical practice through state-of-the-art lectures, clinical case discussions, round-table discussions and debates in order to reach consensus on best practices and inform how treatment guidelines are implemented.
We look forward to welcoming you in the 2020 APACC!
- A program with special focus on the needs in Asia and the Pacific
- A true scientific platform for the regional clinicians and clinical researchers to present their data
- Insights into important clinical developments and updates on ongoing and new trials
- Capacity building workshops and career development sessions for young professionals
- A great opportunity to network with your colleagues throughout Asia
Who should attend?
- Medical professionals involved in daily care of individuals infected with HIV and HIV-HCV, HIV-HBV, HIV-TB and other HIV co-infections
- Clinical, translational and basic researchers, physicians, general practitioners, nurses
- Residents, post-graduates and PhD students
- Government agency personnel, NGO representatives, health authority personnel
- Industry representatives
- Social workers, advocates and community workers
- Other healthcare professionals involved in treating HIV and co-infected patients
This meeting aims to:
- promote dissemination and successful translation of new knowledge regarding HIV and co-infections while facilitating a neutral environment;
- foster new and lasting cross-disciplinary partnerships and collaborations between researchers in HIV, hepatitis, tuberculosis, policy makers, and NGOs, among others in order to improve the knowledge sharing, with the end goal of improving health span within the rapidly growing HIV/AIDS population;
- attract, showcase, and maintain new, early career, and underrepresented investigators to this multidisciplinary area of research and to translate novel findings into clinical practice.
After participating in this activity, the participants will be able:
- describe the major achievements and challenges in antiviral therapy for HIV and/or hepatitis infected patients in the Asia Pacific region;
- identify improved treatment options of their patients;
- initiate (research) collaborations to further improve the level of knowledge on clinical management in the Asia Pacific region;
- use the gained knowledge to make/advocate for appropriate adjustments to policies in public, institutional, and private settings.